Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Mar 08, 2022 8:00 AM - Mar 09, 2022 5:00 PM

(US Eastern Standard Time)

Advertising and Promotion Regulatory Affairs Conference

ADPROMO 2022 HAS GONE VIRTUAL! #AdPromo22 is now a fully virtual event. Use code ADPROMO2022 by March 7 to save $150 for this discounted rate, and join us from the comfort of your home or office. Register today!

Session 8: OPDP Meet and Greet

Session Chair(s)

Fadwa  Almanakly, PHARMD

Fadwa Almanakly, PHARMD

Vice President & Head, Advertising and Promotion, Regulatory Affairs Americas, Bayer Pharmaceuticals, United States

Micheline  Awad, MBA

Micheline Awad, MBA

Sr. Director, Regulatory Advertising, Promotion, and Labeling, Day One Biopharmaceuticals, United States

This session will feature FDA staff members from the Office of Prescription Drug Promotion (OPDP), the Advertising and Promotional Labeling Branch (APLB), and the Regulatory Policy & Guidance Staff in the Office of Product Evaluation and Quality participating in a meet and greet opportunity with conference attendees. Staff members include reviewers, members of leadership, policy analysts and regulatory counsel.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Identify the reviewer or TL for a number of OPDP, APLB or CDRH therapeutic dockets
  • Identify the diversity of educational backgrounds and professional experiences among FDA staff members
  • Efficiently communicate with the reviewer or TL for a therapeutic docket

Speaker(s)

Matthew  Falter, PHARMD, RPH

Matthew Falter, PHARMD, RPH

Deputy Division Director, DAPR2/OPDP, FDA, United States

Speaker

Sapna  Shah, PHARMD

Sapna Shah, PHARMD

Regulatory Review Officer, Division of Advertising and Promotion 1, OPDP, CDER, FDA, United States

Moderator

Susannah  O'Donnell, MPH, RAC

Susannah O'Donnell, MPH, RAC

Team Leader, Division of Advertising and Promotion Review 1, FDA, United States

Speaker

Nazia  Fatima, PHARMD, MBA

Nazia Fatima, PHARMD, MBA

Associate Director Global Regulatory Affiars, Kite Pharma, United States

Speaker

Kathleen  David, BSN

Kathleen David, BSN

Division Director, Division of Promotion Policy, Research, and Operations, OPDP, FDA, United States

Speaker

Amy  Muhlberg, PHD

Amy Muhlberg, PHD

, United States

Speaker

Jennifer  Chen, PHARMD, MBA, RPH

Jennifer Chen, PHARMD, MBA, RPH

Regulatory Review Officer, Division of Advertising and Promotion 1, FDA, United States

Speaker

Deborah  Wolf, JD

Deborah Wolf, JD

Regulatory Counsel, OPEQ , Regulatory Policy, CDRH, FDA, United States

Speaker

Lisa  Stockbridge, PHD

Lisa Stockbridge, PHD

Branch Chief, Advertising and Promotional Labeling Branch, OCBQ, CBER, FDA, United States

Speaker

Oluchi  Elekwachi, PHARMD, MPH

Oluchi Elekwachi, PHARMD, MPH

Program Coordinator, FDA, United States

Speaker

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.